GMO AquAdvantage salmon labeling questions resurface

Screen Shot at PM

AquaBounty Technologies, creator of the first-ever salmon genetically engineered for commercial production, doesn’t have to notify Canadian buyers that its fish is genetically engineered, but it is considering doing so….

The….Maynard, Massachusetts-based company, with indoor grow-out facilities both in….Albany, Indiana, and also the Canadian community of Rollo Bay in Prince Edward Island, is about to begin commercial production of AquaAdvantage salmon….[and the fish] is expected to hit the Canadian market by the third quarter of 2020.

After a four-year study, Health Canada declared, in May 2016, that AquaBounty’s salmon is “safe and nutritious” and therefore no labeling is required. However, the US Department of Agriculture (USDA), in December, issued proposed guidelines that would have genetically engineered foods called “bioengineered”….

Dave Conley, AquaBounty’s director of corporate communications [said] his company [is] now trying to sort out what would be required to comply with the USDA’s guidance but could be inclined to maintain the same approach in both countries.

However, Lucy Sharrat, a coordinator at the Canadian Biotechnology Action Network, also in Halifax, said on the program that she doesn’t expect AquaBounty to follow through on any clear labeling.

Read full, original article: AquaBounty keeping GE salmon labeling options open in Canada

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-May-7-2026-12_16_37-PM-2
Viewpoint: Are cancer rates ‘skyrocketing’ as RFK, Jr. and MAHA claims? The evidence says mostly the opposite
Screenshot-2026-04-22-at-10.46.29-AM
Viewpoint: How to counter science disinformation? Science journalist offers 12 practical tips
Screenshot-2026-04-13-at-1.39.26-PM
Viewpoint: ‘Safer for children?’ Stonyfield yogurt under fire for deceptive organic marketing
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
bigstock opioids on chalkboard with rol
GLP podcast: 'Safe injection sites': enabling drug addiction or saving lives?
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.